LP-44: Difference between revisions

Page 1
Page 2
Content deleted Content added
No edit summary
m Added UNII
 
(25 intermediate revisions by 20 users not shown)
Line 1: Line 1:
{{Short description|Chemical compound}}
{{Drugbox
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 449685025
| IUPAC_name = 4-[2-(methylthio)phenyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide
| IUPAC_name = 4-[2-(methylthio)phenyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide
| image = LP-44_structure.png
| image = LP-44_structure.png
Line 14: Line 17:
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| legal_status =
| routes_of_administration =
| routes_of_administration =


<!--Pharmacokinetic data-->
<!--Pharmacokinetic data-->
Line 21: Line 24:
| metabolism =
| metabolism =
| elimination_half-life =
| elimination_half-life =
| excretion =
| excretion =


<!--Identifiers-->
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|CAS}}
| CAS_number = 824958-12-5
| CAS_number = 824958-12-5
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = M5K3JUP5EZ
| ATC_prefix =
| ATC_prefix =
| ATC_suffix =
| ATC_suffix =
| PubChem = 11224758
| PubChem = 11224758
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 9399811


<!--Chemical data-->
<!--Chemical data-->
| C=27 | H=37 | N=3 | O=1 | S=1
| C=27 | H=37 | N=3 | O=1 | S=1
| molecular_weight = 451.666 g/mol
| smiles = c3cccc2c3CCCC2NC(=O)CCCCCN(CC4)CCN4c1ccccc1SC
| smiles = c3cccc2c3CCCC2NC(=O)CCCCCN(CC4)CCN4c1ccccc1SC
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C27H37N3OS/c1-32-26-15-7-6-14-25(26)30-20-18-29(19-21-30)17-8-2-3-16-27(31)28-24-13-9-11-22-10-4-5-12-23(22)24/h4-7,10,12,14-15,24H,2-3,8-9,11,13,16-21H2,1H3,(H,28,31)
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = JNBBJUHCODFLEG-UHFFFAOYSA-N
}}
}}


'''LP-44''' is a drug which acts as a potent and selective [[agonist]] at the [[5-HT7 receptor|5HT<sub>7</sub>]] [[serotonin]] [[Receptor (biochemistry)|receptor]]. While LP-44 is less selective than the related compound [[LP-12]], it has been more widely used in research and has been used to show the complex role of 5-HT<sub>7</sub> receptors in several aspects of brain function, including regulation of the sleep-wake cycle and roles in stress, learning and memory.<ref name="pmid18466985">{{cite journal |author=Monti JM, Leopoldo M, Jantos H |title=The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat |journal=Behavioural Brain Research |volume=191 |issue=2 |pages=184–9 |year=2008 |month=August |pmid=18466985 |doi=10.1016/j.bbr.2008.03.025 |url=}}</ref><ref name="pmid21371532">{{cite journal |author=Xu Y, Zhang C, Wang R, Govindarajan SS, Barish PA, Vernon MM, Fu C, Acharya AP, Chen L, Boykin E, Yu J, Pan J, O'Donnell JM, Ogle WO |title=Corticosterone induced morphological changes of hippocampal and amygdaloid cell lines are dependent on 5-HT7 receptor related signal pathway |journal=Neuroscience |volume=182 |issue= |pages=71–81 |year=2011 |month=May |pmid=21371532 |doi=10.1016/j.neuroscience.2011.02.042 |url=}}</ref><ref name="pmid21459634">{{cite journal |author=Monti JM |title=Serotonin control of sleep-wake behavior |journal=Sleep Medicine Reviews |volume=15 |issue=4 |pages=269–81 |year=2011 |month=August |pmid=21459634 |doi=10.1016/j.smrv.2010.11.003 |url=}}</ref><ref name="pmid21538661">{{cite journal |author=Costa L, Trovato C, Musumeci SA, Catania MV, Ciranna L |title=5-HT(1A) and 5-HT(7) receptors differently modulate AMPA receptor-mediated hippocampal synaptic transmission |journal=Hippocampus |volume= |issue= |pages= |year=2011 |month=April |pmid=21538661 |doi=10.1002/hipo.20940 |url=}}</ref>
'''LP-44''' is a drug which acts as a potent and selective [[agonist]] at the [[5-HT7 receptor|5HT<sub>7</sub>]] [[serotonin receptor]]. While LP-44 is less selective than the related compound [[LP-12]], it has been more widely used in research and has been used to show the complex role of 5-HT<sub>7</sub> receptors in several aspects of brain function, including regulation of the sleep-wake cycle and roles in stress, learning and memory.<ref name="pmid18466985">{{cite journal |vauthors=Monti JM, Leopoldo M, Jantos H |title=The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat |journal=Behavioural Brain Research |volume=191 |issue=2 |pages=184–9 |date=August 2008 |pmid=18466985 |doi=10.1016/j.bbr.2008.03.025 |s2cid=14310667 }}</ref><ref name="pmid21371532">{{cite journal |vauthors=Xu Y, Zhang C, Wang R, Govindarajan SS, Barish PA, Vernon MM, Fu C, Acharya AP, Chen L, Boykin E, Yu J, Pan J, O'Donnell JM, Ogle WO |title=Corticosterone induced morphological changes of hippocampal and amygdaloid cell lines are dependent on 5-HT7 receptor related signal pathway |journal=Neuroscience |volume=182 |pages=71–81 |date=May 2011 |pmid=21371532 |doi=10.1016/j.neuroscience.2011.02.042 |s2cid=1452141 }}</ref><ref name="pmid21459634">{{cite journal |author=Monti JM |title=Serotonin control of sleep-wake behavior |journal=Sleep Medicine Reviews |volume=15 |issue=4 |pages=269–81 |date=August 2011 |pmid=21459634 |doi=10.1016/j.smrv.2010.11.003 }}</ref><ref name="pmid21538661">{{cite journal |vauthors=Costa L, Trovato C, Musumeci SA, Catania MV, Ciranna L |title=5-HT(1A) and 5-HT(7) receptors differently modulate AMPA receptor-mediated hippocampal synaptic transmission |journal=Hippocampus |volume= 22|issue= 4|pages= 790–801|date=April 2011 |pmid=21538661 |doi=10.1002/hipo.20940 |s2cid=718851 }}</ref>


==See also==
==See also==
Line 46: Line 57:


{{Serotonergics}}
{{Serotonergics}}
{{Piperazines}}


[[Category:Serotonin receptor agonists]]
[[Category:5-HT7 agonists]]
[[Category:1-Aminotetralins]]
[[Category:Phenylpiperazines]]